Vanda Pharmaceuticals Inc. (VNDA) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mihael Hristos Polymeropoulos

President and CEO

—

$1.28M (1)

−$1.28M

2,704,496

4.47%

$10.29M

+44.5%

Kevin Patrick Moran

SVP, CFO & Treasurer

—

$350.82K (1)

−$350.82K

411,380

0.6804%

$1.56M

+79.8%

Timothy Williams

SVP & General Counsel

—

$350.76K (1)

−$350.76K

377,450

0.6243%

$1.44M

+91.8%

Gunther Birznieks

SVP, Business Development

—

$350.73K (1)

−$350.73K

494,197

0.8174%

$1.88M

+57.6%

Joakim Wijkstrom

SVP, Chief Marketing Officer

—

$254.59K (1)

−$254.59K

333,469

0.5515%

$1.27M

+156.9%

Tage Honore

Director

—

$240.90K (1)

−$240.90K

135,069

0.2234%

$513.83K

+110.2%

Charles Cliff Duncan

Director

$38.09K (3)

—

+$38.09K

108,701

0.1798%

$413.52K

—

Richard W Dugan

Director

—

219,054

0.3623%

$833.33K

+85.3%

Phaedra Chrousos

Director

—

164,950

0.2728%

$627.50K

+157.2%

Anne Sempowski Ward

Director

—

160,667

0.2657%

$611.21K

+168.5%

Stephen Ray Mitchell

Director

—

112,846

0.1866%

$429.29K

+126.3%

Daniel Patrick McGuire

SVP, GC and Secretary

—

109,982

0.1819%

$418.39K

+266.8%

Vanda Pharmaceuticals Inc.

What the insiders did Net selling

By person